https://www.washingtonpost.com/business/2022/05/11/baby-formula-shortage-similac-alimentum-elecare-fda/
Although devastating for all concerned. The Abbott recall will cause shock waves through the IF industry world wide, product trust is
paramount for parents. As DB iterated in the half yearly report he is targeting South Korea and Vietnam, hopefully all the disruptions will
trigger the other Asian markets to diversify supply and minimise shortages. The current microchip shortages are a prime example of why diversification is a must with current world challenges..
https://www.washingtonpost.com/business/2022/05/11/baby-formula-s...
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.85 |
Change
-0.060(0.87%) |
Mkt cap ! $4.952B | |||
| Open | High | Low | Value | Volume |
| $6.83 | $6.87 | $6.78 | $8.532M | 1.250M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2151 | $6.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.85 | 27162 | 5 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| A2M (ASX) Chart |